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Abstract: [Cu(phen)2]
2+ (phen = 1,10-phenanthroline) is
the first and still one of the most efficient artificial nucle-
ases. In general, when the phen ligand is modified, the
nucleolytic activity of its CuII complex is significantly re-
duced. This is most likely due to higher steric bulk of such
ligands and thus lower affinity to DNA. CuII complexes
with phen ligands having fluorinated substituents (F, CF3,
SF5, SCF3) surprisingly showed excellent DNA cleavage ac-
tivity—in contrast to the unsubstituted [Cu(phen)2]
2 +—in
the absence of the otherwise required classical, bioabun-
dant external reducing agents like thiols or ascorbate. This
nucleolytic activity correlates well with the half-wave po-
tentials E1/2 of the complexes. Cancer cell studies show cy-
totoxic effects of all complexes with fluorinated ligands in
the low mm range, whereas they were less toxic towards
healthy cells (fibroblasts).
A few decades ago, Sigman et al. discovered the nucleolytic
activity of bis(1,10-phenanthroline)copper(II) [Cu(phen)2]
2 + to-
wards dsDNA in the presence of O2 and 3-mercaptopropionic
acid as a reducing agent. The active species was shown to be
the corresponding CuI complex. Thus, reducing agents are
mandatory for initiating the generation of reactive oxygen spe-
cies (ROS), which are required for exerting oxidative damage
to DNA.[1] Different groups have tried to enhance and manipu-
late this nucleolytic activity, for example, via substitution of hy-
drogen atoms on the ligand scaffold. DNA cleavage can even
be inhibited as by 2,9-dimethylphenanthroline (neocuproine),
which scavenges CuI and blocks the redox cycle involving the
production of ROS. All [CuL2]
2 + species (L = phen derivatives
like dipyrido[3,2-d:2’,3’-f]quinoxaline (dpq) and dipyrido[3,2-
a:2’,3’-c]phenazine (dppz)) investigated until today required ex-
ternal reducing agents for oxidative DNA cleavage like thiols or
ascorbate.[2–5] The only reported examples where no addition
of external reductants was necessary were obtained by linkage
of two [Cu(phen)2]
2 + moieties by aliphatic and aromatic dicar-
boxylates. A “self-activation” mechanism for ROS formation
based on a ligand radical species was proposed.[6]
Our group has focused on the manipulation of the redox
properties of [Cu(phen)2]
2+ complexes via substitution of the
ligand scaffold with fluorine or fluorine-containing groups. In
this report, we are presenting the synthesis of new homoleptic
CuII complexes with phen ligands having fluorine or fluorinat-
ed substituents at positions 5 and/or 6 (Figure 1). The interac-
tion of these complexes with DNA, their nucleolytic activity as
well as their cytotoxic properties are described herein. Fluo-
rine-containing phen derivatives were obtained via Skraup syn-
thesis as described previously, starting from prefunctionalized
nitroaniline and nitroquinoline precursors.[7] Such phen com-
plexes are barely known to the literature even with other
metals. To the best of our knowledge, the only examples up to
date represent a homoleptic CuI complex with two to four CF3
Figure 1. CuII complexes with fluorinated phen ligands. For i)–v) only one of
two possible isomers generated by asymmetric substitution at positions 5
and 6 of the phen moiety is shown.
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groups in the phen moiety and PdII complexes [PdCl2(L)] and
[PdCl2(PPh3)(L)] with L = 4,7-dichloro-5-fluoro-2,9-dimethyl-1,10-
phenanthroline.[8, 9] Besides that, theoretical investigations have
been carried out for Ru complexes with 5,6-difluoro-1,10-phe-
nanthroline (F2phen) and 5-trifluoromethyl-1,10-phenanthro-
line (CF3phen).
[10, 11]
The corresponding CuII complexes were obtained by allow-
ing copper(II) nitrate to react with the fluorinated phen deriva-
tives (cf. S-1). Depending on the crystallization conditions, two
different solvates of the complex [Cu(F2phen)2(NO3)]NO3 were
obtained, the solid-state molecular structures of which were
determined by X-ray diffraction (see Experimental Section).
Crystallization from water/ methanol/diethyl ether afforded a
dihydrate (Cu(F2phen)2(a)), in which the Cu center is hexa-co-
ordinated by two bidentate F2phen ligands, one monodentate
nitrate ligand, and one aqua ligand in a typical square-bipyra-
midal fashion, with the axial positions being defined by an N
atom and the nitrate O atom (Figure 2 a). This arrangement is
most likely supported by an intramolecular O@H···O bond be-
tween the nitrate and aqua ligands. A different picture was ob-
served when crystallization was conducted in the absence of
water, affording a mono-MeOH solvate (Cu(F2phen)2(b)). In this
case, the CuII ion displays a somewhat square-pyramidal coor-
dination by the two F2phen ligands and one nitrato ligand,
with an N atom defining the apical position (Figure 2 b). How-
ever, the structure of the MeOH solvate can be interpreted as
an intermediate case between penta- and hexa-coordination,
as the sixth coordination site is occupied by a weak, additional
Cu···O contact to the nitrato ligand. The complex [Cu(Fphe-
n)2(ONO2)]NO3, even though crystallizing from wet methanol
with one equivalent of crystal water, also displays only a
penta-coordination (cf. Figure S-3.3). However, in this case the
arrangement of the ligands is better described as trigonal-bi-
pyramidal, with two N atoms defining the axial positions. This
coordination has been observed most frequently in previously
reported [Cu(phen)2]
2 + derivatives.[12–15]
The CuII complexes with fluorinated phen ligands showed
remarkable changes of half-wave potentials E1/2 depending on
the substituents of their ligands (Table 1, Figure S-4). The CuII
complex with two fluorine atoms at the phen ligand was the
easiest to reduce. As a result, substitution with a strongly elec-
tron-withdrawing group like F or CF3 (and even more with two
of them) stabilizes the corresponding CuI species. Similarly,
substitution of the phen scaffold with CF3 groups in positions
2 and 9 led to the highest potential for CuII/CuI ever measured
in a reversible redox process for a mononuclear copper com-
plex (+ 1.1 V vs. FcH/FcH+ ; FcH = ferrocene).[16] The electron-
withdrawing capability of the substituents (H<F<CF3&
SCF3<SF5)
[17, 18] correlates with the increase in half-wave poten-
tial of the corresponding copper complexes. A similar correla-
tion of the electron-withdrawing properties of substituents
and the reduction potential has been observed before for ex-
ample, for metalloporphyrins.[19]
With these trends in mind, the nucleolytic activity of the
complexes in the presence and absence of reducing agents to-
wards supercoiled plasmid DNA was investigated. In the
presence of ascorbic acid (Figure 3, representative agarose gel
Figure S-5.1) the unmodified [Cu(phen)2]
2 + species showed the
highest cleavage efficiency of pBR322 DNA followed by the
monofluorinated [Cu(Fphen)2]
2 + as indicated by formation of
linear DNA. The F2phen and CF3phen complexes showed
nearly equal cleavage efficiency leading to about 80 %
open circular and a little amount of linear DNA after 60 min.
The sulfur-containing species [Cu(SCF3phen)2]
2 + and
[Cu(SF5phen)2]
2+ turned out to be most ineffective nucleases,
generating only about 60 % cleaved DNA.








2+ , correlates well with the half-wave potentials
with the exception of the complex with the difluorinated
ligand, F2phen, which showed the least negative E1/2 value. In
order to completely elucidate the nucleolytic activity, not only
Figure 2. Molecular structures of a) the dihydrate Cu(F2phen)2(a), and b) the
methanol solvate Cu(F2phen)2(b) in the solid state.
Table 1. Half-wave potentials E1/2 of Cu
II complexes vs. FcH/FcH+ in a
0.1 m KCl solution (water/acetonitrile = 9:1) at room temperature.
Complex E1/2 [V] Complex E1/2 [V]
[Cu(phen)2]
2 + @0.32 [Cu(CF3phen)2]2 + @0.21
[Cu(Fphen)2]
2 + @0.23 [Cu(SCF3phen)2]2 + @0.16
[Cu(F2phen)2]
2+ @0.11 [Cu(SF5phen)2]2+ @0.14
Figure 3. Graphical representation of cleavage of pBR322 DNA
(0.025 mg mL@1) with different CuII complexes (10 mm) in the presence of as-
corbic acid (250 mm) in 50 mm Tris-HCl (pH 7.4) after 60 min of incubation at
37 8C. First lane: DNA reference without ascorbic acid. Last lane: DNA refer-
ence with ascorbic acid.




redox activity, but also affinity to DNA has to be considered.
DNA affinity was determined with DNA melting experiments
(cf. section S-6) and ethidium bromide (EB) displacement
assays with CT-DNA (cf. section S-7, Table 2).
The melting temperature Tm of CT-DNA was increased by
13 8C by the most efficient DNA cleaving agent [Cu(phen)2]
2+ ,
whereas for the fluorinated species DTm of only 1 8C to 8 8C
was observed (cf. S6). Likewise, EB displacement showed high-
est affinity, that is, highest KSV and Kapp constants (Table 2) for
the complexes of highest nucleolytic activity ([Cu(phen)2]
2 + >
[Cu(Fphen)2]








Small differences in the outcome of the DNA melting and EB
displacement studies probably result from the fact that differ-
ent mechanisms underlie the two methods. Nevertheless, both
experiments indicated a dependence of the strength of DNA
binding on the steric bulk of the complexes. The larger the
substituent (e.g. , CF3 vs. F) and the higher the grade of substi-
tution (2 V F vs. F) on the phen scaffold, the lower was the af-
finity of the resulting complexes to DNA. Accordingly, also a
lower nucleolytic activity of the complexes was observed.
Interestingly, in the absence of any added external reducing
agents unexpectedly high nucleolytic activity in case of the flu-
orine-containing complexes was observed—in contrast to the
parent compound (Figure 4, representative agarose gel Fig-
ure S-5.2). [Cu(F2phen)]
2 + was 2.5 times more active than
[Cu(phen)2]
2 + , which had an activity barely above the back-
ground (DNA reference). When Tris-HCl was used instead of
MOPS as a buffer (Figure S-5.3), the trends were the same as in
MOPS, however, plasmid DNA was even cleaved into its linear
form by [Cu(F2phen)]
2 + . It should be mentioned though that
Tris (tris(hydroxymethyl)-aminomethane), which is commonly
used in such assays, is a potential competitive ligand for CuII.[20]
According to the literature-reported association constants logK
(Table S-5) also ternary complexes with Tris and phen as li-
gands are conceivable to play a role in the DNA cleavage reac-
tion. (In case of the cleavage reaction in the presence of ascor-
bate, the buffer change did not reveal any differences.)
The nucleolytic activity in the absence of added external re-
ducing agents correlates linearly with the half-wave potentials
E1/2 of the complexes (Table 1, cf. Figure S-5.5 correlation coeffi-
cient r = 0.86). With the reduction potential becoming less neg-
ative the CuI species is expected to be stabilized by the respec-
tive electron-withdrawing substituents at the phen moiety.
Such a stabilization apparently leads to higher DNA cleavage
rates. As a consequence, a higher degree of fluorination
caused a higher activity of the complexes (cf. [Cu(F2phen)2]
2 +
vs. [Cu(Fphen)2]
2 +) in DNA cleavage.
Cleavage without the participation of external reducing
agents like ascorbate might indicate a hydrolytic cleavage
mechanism, however, also photocleavage or oxidative mecha-
nisms initiated by reducing species in the incubation solution
are conceivable. Hydrolytic cleavage was excluded due to
demonstrated O2- and light-dependence of the cleavage reac-
tion: Under O2-depleted conditions DNA cleavage activity of
[Cu(F2phen)2]
2 + decreased indicating an oxidative mechanism.
When the reaction was carried out in the dark, the activity de-
creased even more (additive effects of light and O2) pointing
to a photocleavage process (Figure S-5.4). Whereas the results
were not conclusive for the parent compound—probably due
to low cleavage activity—a process similar to the one of type I
photosensitizers could be proposed for [Cu(F2phen)2]
2 + .[21]
Also, there is indication from the literature that photoreduc-
tion of CuII to CuI in phen complexes is possible. In line with
what we have observed, the parent compound is photochemi-
cally rather inert, but higher activity is expected for species
with less negative redox potentials, that is, higher tendency for
forming CuI.[22] Such CuI species are prone to ROS genera-
tion.[23]
Alternatively, DNA itself could serve as a reducing agent.
DNA bases like guanine exhibit a relatively low oxidation po-
tential,[24] especially when considering Watson–Crick G·C base
pairing.[25, 26] A pathway involving CuIII species like in the case
of CuII hydroxysalene complexes[27] is improbable due to the
electron-withdrawing property of the fluorine-containing func-
tional groups.[28]
To test for ROS involved in the cleavage reaction scavenging
experiments were carried out. The quenching of cleavage ac-
Table 2. Stern–Volmer constants (KSV) and apparent binding constants
(Kapp) of different complexes to CT-DNA (20 mm) derived from EB displace-
ment assay in 10 mM Tris-HCl.
Complex KSV [m




2 + 2.57 V 104 38.9 1.29 V 106
[Cu(Fphen)2]
2 + 1.73 V 104 57.8 8.65 V 105
[Cu(F2phen)2]
2+ 6.68 V 103 149.7 3.34 V 105
[Cu(CF3phen)2]
2 + 7.59 V 103 131.8 3.80 V 105
[Cu(SCF3phen)2]
2+ 1.03 V 104 97.1 5.15 V 105
[Cu(SF5phen)2]
2 + 8.89 V 103 112.5 4.45 V 105
[a] Concentration at which 50 % of EB fluorescence is quenched.
Figure 4. Graphical representation of cleavage of pBR322 DNA
(0.025 mg mL@1) with different CuII complexes (100 mm) in 50 mm MOPS
(pH 7.4) after 60 min of incubation at 37 8C. First lane: DNA reference.




tivity by catalase (cat.) and superoxide dismutase (SOD)
showed the participation of hydrogen peroxide and superox-
ide (Figure 5). No quenching was observed in case of DMSO
and NaN3 which makes it unlikely that freely diffusible hydroxyl
radicals or singlet oxygen are involved as ROS. It seems that
the formation of ROS proceeds in a similar manner like the for-
mation of ROS in the presence of external reducing agents like
ascorbate including the stepwise one-electron reduction of
oxygen to superoxide and furthermore to a peroxo species.[29]
In order to evaluate the influence of fluorine-containing sub-
stituents on cytotoxicity, the MTT assay was carried out with
MCF-7 breast cancer cells. Figure 6 shows cell viability in the
presence of 10 mm CuII complexes with fluorinated ligands in
comparison to [Cu(phen)2]
2 + with unsubstituted phen.
[Cu(CF3phen)2]
2 + , [Cu(SCF3phen)2]
2 + and [Cu(SF5phen)2]
2 +
showed nearly the same cytotoxicity as the parent compound
[Cu(phen)2]
2 + in MCF-7 cells (IC50 2.2–2.7 mm vs. 2.3 mm, Fig-
ure S-8, Table S-8), whereas [Cu(Fphen)2]
2 + and even more
[Cu(F2phen)2]
2 + distinctly exhibited a much lower cytotoxicity
with IC50 values being two to three times higher. These trends
were also observed in the more aggressive breast cancer cells
MDA-MB-231[30] and in fibroblasts, the latter ones representing
healthy cells. The cytotoxicity was lower for all compounds in
these cell lines, whereby the fluorinated compounds were in
general clearly less cytotoxic towards fibroblasts than cancer
cells when compared to [Cu(phen)2]
2 + . As an example, the IC50
value of [Cu(F2phen)2]
2 + incubated with fibroblasts was twice
as high as the one in cancer cells indicating that it has a slight-
ly reduced cytotoxic effect towards non-cancer cells.
There is no correlation between the cytotoxicity and nucleo-
lytic activity and DNA affinity of the complexes so that also
other mechanisms have to be considered in inducing cell
death. Indeed, lipophilicity seems to be decisive here to ex-
plain the cytotoxicity trends for the fluorinated compounds:
CF3, SCF3 and SF5 show higher lipophilicity increments in com-
parison to F,[31] which was confirmed for the complexes
through the water/n-octanol partition experiment[32, 33] (log P
for complexes with phen substituents H<F<2 V F<CF3<
SCF3<SF5, Table S-9). The compounds with the latter substitu-
ents (CF3, SCF3, SF5) showed higher (less negative) log P values
(higher lipophilicity) than the ones with the first ones (F, 2 V F)
which correlates well with the observed cytotoxic behavior.
The fact that the parent compound representing the least lipo-
philic complex, [Cu(phen)2]
2 + , is similarly cytotoxic as the most
lipophilic ones, confirms that lipophilicity is only one factor de-
termining cytotoxicity.
It has to be mentioned that recent findings indicate that CuII
phen complexes, although stable at pH 7.4 and 37 8C in water
(as demonstrated in Figure S-10 by UV/VIS spectroscopy) most
probably decompose in cell culture media. Interaction with cell
components and cell death may be due to Cu ions and phen
acting separately.[34] Also, thiol-rich molecules such as metallo-
thioneins and glutathione, abundant in the cytosol and nu-
cleus, might reduce CuII and scavenge reduced CuI even
before the complex reaches its potential target, the DNA.[35]
Such behavior is even more probable for longer incubation
times (>24 h). However, in these reported studies the amount
of Cu accumulated in cell compartments was different for dif-
ferent phen derivatives, indicating that efficiency of uptake,
and eventually also cell death, indeed depends on the ligand
moiety.[34]
In conclusion, we have synthesized CuII complexes of the
type [Cu(phen)2]
2 + with fluorinated phen ligands, which act as
chemical nucleases without the otherwise required classical,
bioabundant external reducing agents. This modification
shows a high value for the construction of such nucleases via
simple derivatization of ligands, changing the electronic prop-
erties of the [Cu(phen)2]
2 + complex. Substitution of the ligands
with fluorine-containing groups is responsible for a less nega-
tive reduction potential of the complexes thus enabling an ac-
tivation of the nuclease without external reducing agent. All
complexes showed high cytotoxicity in two different breast
cancer cell lines (IC50<10 mm), and the more lipophilic the
ligand, the higher the cytotoxic effect was. Among the fluori-
nated complexes, despite of being the least cytotoxic com-
pound, [Cu(F2phen)2]
2 + stood out by showing the most dis-
tinctive differentiation between cancer and healthy cells. This
complex was also the most efficient DNA cleaver outperform-
ing the parent compound [Cu(phen)2]
2 + , which does need an
Figure 5. Cleavage of pBR322 DNA (0.025 mg mL@1) with [Cu(F2phen)2]
2+
(100 mm) in the presence of different ROS scavengers (detailed conditions in
the Supporting Information) in 50 mm MOPS (pH 7.4) after 60 min of incuba-
tion at 37 8C. First lane: DNA reference without complex and ROS scaveng-
ers. Second lane: reference without ROS scavengers.
Figure 6. Cytotoxicity of different complexes (10 mm) to MDA-MB-231 and
MCF-7 breast cancer cells as well as fibroblasts resulting from an MTT assay
after 48 h of incubation.




external reducing agent like ascorbate for initiation of its nu-
cleolytic activity. It will be of interest to further investigate the
mechanism of activation of nucleolytic activity.
Experimental Section
For the synthesis of complexes, methods and molecular and cell
biological studies see the Supporting Information.
Human dermal fibroblasts isolated from neonate foreskin biopsies
after ethical approval (EA1/081/13, Ethics Committee from the
Charit8 Campus Mitte, Berlin) and with informed parental consent,
were provided by the Institute of Pharmacy (Freie Universit-t
Berlin).
Deposition numbers 2032216 (Cu(F2phen)2(a)) and 2032217
(Cu(F2phen)2(b)) contain the supplementary crystallographic data
for this paper. These data are provided free of charge by the joint
Cambridge Crystallographic Data Centre and Fachinformationszen-
trum Karlsruhe Access Structures service.
Acknowledgements
We acknowledge the DFG graduate school GRK 1582 (“Fluorine
as a Key Element”) for financial support. Open access funding
enabled and organized by Projekt DEAL.
Conflict of interest
The authors declare no conflict of interest.
Keywords: artificial nucleases · copper complexes ·
cytotoxicity · fluorination · phenanthroline
[1] D. S. Sigman, D. R. Graham, V. D’Aurora, A. M. Stern, J. Biol. Chem. 1979,
254, 12269 – 12272.
[2] B. K. Santra, P. A. N. Reddy, G. Neelakanta, S. Mahadevan, M. Nethaji,
A. R. Chakravarty, J. Inorg. Biochem. 2002, 89, 191 – 196.
[3] T. Gupta, S. Dhar, M. Nethaji, A. R. Chakravarty, Dalton Trans. 2004,
1896 – 1900.
[4] Z. Molphy, C. Slator, C. Chatgilialoglu, A. Kellett, Front. Chem. 2015, 3,
28.
[5] M. S. A. Begum, S. Saha, A. Hussain, A. R. Chakravarty, Indian J. Chem. A
2009, 48, 9 – 14.
[6] a) A. Kellett, M. O’Connor, M. McCann, M. McNamara, P. Lynch, G. Rosair,
V. McKee, B. Creaven, M. Walsh, S. McClean, A. Foltyn, D. O’Shea, O.
Howe, M. Devereux, Dalton Trans. 2011, 40, 1024 – 1027; b) A. Prisecaru,
M. Devereux, N. Barron, M. McCann, J. Colleran, A. Casey, V. McKee, A.
Kellett, Chem. Commun. 2012, 48, 6906 – 6908; c) A. Kellett, Mark
O’Connor, M. McCann, O. Howe, A. Casey, P. McCarron, K. Kavanagh, M.
McNamara, S. Kennedy, D. D. May, P. S. Skell, D. O’Shea, M. Devereux,
Med. Chem. Commun. 2011, 2, 579 – 584.
[7] C. Ledtke, A. Haupt, M. Wozniak, N. Kulak, J. Fluorine Chem. 2017, 193,
98 – 105.
[8] M. Y. Livshits, B. J. Reeves, N. J. DeWeerd, S. H. Strauss, O. V. Boltalina,
J. J. Rack, Inorg. Chem. 2020, 59, 2781 – 2790.
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